Clinical • P1 data • Combination therapy
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • ROR1 (Receptor Tyrosine Kinase Like Orphan Receptor 1) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10)
|
MRD4 negative
|
Imbruvica (ibrutinib) • NVG-111